The world’s deadliest creature – the mosquito
Herpes zoster virus of shingles
About us We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.
Read morePress releases
- ViiV Healthcare announces CHMP Positive Opinion for Dovato® (dolutegravir/lamivudine) as a once-daily, single-pill, two-drug regimen for the treatment of HIV infection
- US FDA approves ViiV Healthcare’s Dovato (dolutegravir/lamivudine), the first, once-daily, single-tablet, two-drug regimen for treatment-naïve HIV-1 adults
- ViiV Healthcare announces Juluca (dolutegravir/rilpivirine) maintains HIV viral suppression at 148-weeks
Tweets from GSK
-
GSK @GSK
Immunisation is one of the most successful public health initiatives ever, but many children still miss out on their vaccinations. We’re trying to bridge that gap #VaccinateForLife #WIW2019 #VaccinesWork
about 50 minutes ago -
GSK @GSK
#DYK we spent a year screening 2 million compounds in our library for activity against the malaria parasite and put the data into the public domain? This open innovation helps to drive scientific progress to tackling malaria. #WorldMalariaDay #EndMalaria #OpenInnovation
about 4 hours ago
-
GSK @GSK
Meet Justin Green, the doctor vital in the discovery of the first treatment for relapsing malaria in 60 years. #WorldMalariaDay #endmalaria
about 21 hours ago
